Moreover, among all molecular changes in hepatocellular carcinoma (HCC), NRF2 activation has been revealed as a more prominent pathway contributing to the progression of precancerous lesions to malignancy. This evidence concerns the gene NFE2L2 and hepatocellular carcinoma.